K022489 is an FDA 510(k) clearance for the SUMMIT MEDICAL LTD CELLTRANS POSTOPERATIVE AUTOTRANSFUSION SYSTEM, MODELS ABT4510, ABT4512 & ABT4514. This device is classified as a Apparatus, Autotransfusion (Class II - Special Controls, product code CAC).
Submitted by Summit Medical , Ltd. (Stevenage Hertfordshire, GB). The FDA issued a Cleared decision on October 9, 2002, 72 days after receiving the submission on July 29, 2002.
This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.5830.